These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22124108)

  • 1. Diffuse osteosclerosis-associated acute myeloid leukemia.
    Ward DE; Fondaw MB; Shroff SK; Reddy VS; Khaled YA
    J Clin Oncol; 2012 Jan; 30(1):e3-4. PubMed ID: 22124108
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
    Miyazaki Y
    Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of peripheral blood stem cells as rescue after myeloablative therapy.
    Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.
    Shin HJ; Kim HJ; Sohn SK; Min YH; Won JH; Kim I; Yoon HJ; Lee JH; Jo DY; Joo YD; Jung CW; Lee KH; ; Chung JS; Ahn JS; Kim SJ; Lee JH; Choi SJ; Lee JH; Bae SH; Hong DS; Zang DY; Kim SH; Lee JL; Bang SM
    Jpn J Clin Oncol; 2010 Jun; 40(6):556-66. PubMed ID: 20185460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure of acute myelocytic leukemia in adults: a reality.
    Geller RB; Saral R; Karp JE; Santos GW; Burke PJ
    Leukemia; 1990 May; 4(5):313-5. PubMed ID: 2201825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of post-liver transplant acute myeloid leukemia in Korean adults: review of bibliographies and comparison with post-renal transplant acute myeloid leukemia.
    Cho YU; Chi HS; Park CJ; Seo EJ; Lee JH; Lee JH; Lee SG
    Ann Hematol; 2008 Jun; 87(6):513-4. PubMed ID: 18299830
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
    Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
    Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
    Koh Y; Kim I; Bae JY; Song EY; Kim HK; Yoon SS; Lee DS; Park SS; Park MH; Park S; Kim BK
    Jpn J Clin Oncol; 2010 Nov; 40(11):1037-45. PubMed ID: 20587614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the secondary colony-plating efficiency of blast progenitors and the remission induction outcome of acute myeloblastic leukemia patients.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1624-9. PubMed ID: 3247826
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standard therapies for acute myeloid leukemia].
    Matsumura I
    Rinsho Ketsueki; 2009 Oct; 50(10):1389-400. PubMed ID: 19915347
    [No Abstract]   [Full Text] [Related]  

  • 13. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
    Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
    Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
    Vogler WR; Velez-Garcia E; Omura G; Raney M
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute myelogenous leukemia in elderly patients].
    Mori M
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):192-6. PubMed ID: 10879065
    [No Abstract]   [Full Text] [Related]  

  • 17. One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.
    Jourdan E; Rigal-Huguet F; Marit G; Vey N; Dastugue N; Fegueux N; Molina L; Gastaut JA; Legros L; Zerazhi H; Cailleres S; Bauduer F; Bordessoule D; Attal M; Blaise D; Pigneux A;
    Br J Haematol; 2005 May; 129(3):403-10. PubMed ID: 15842665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
    HoĊ‚owiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
    Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA.
    Petti MC; Mandelli F; Vegna ML; Broccia G; Carotenuto M; De Rosa F; Di Marco P; Di Raimondo F; Fioritoni G; Leone G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.